Researchers presented an exploratory analysis comparing OCT biomarkers in a Phase 1b study of ONL1204 in patients with ...

The Food and Drug Administration has granted Fast Track designation to urcosimod for the treatment of neuropathic corneal pain.

More than 75,000 cases comprising more than 1.8 million cartons of consumer level dry eye drops have been voluntarily recalled.